Grifols, S.A. (BME:GRF)
Spain
· Delayed Price · Currency is EUR 8.13
-0.03 (-0.34%)
May 9, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Biopharma | 6.14B |
Log In |
Log In |
Log In |
Log In |
| Biopharma Growth | 10.51% |
Log In |
Log In |
Log In |
Log In |
| Diagnostic | 644.90M |
Log In |
Log In |
Log In |
Log In |
| Diagnostic Growth | -3.79% |
Log In |
Log In |
Log In |
Log In |
| Bio Supplies | 215.66M |
Log In |
Log In |
Log In |
Log In |
| Bio Supplies Growth | 34.83% |
Log In |
Log In |
Log In |
Log In |
| Other | 209.23M |
Log In |
Log In |
Log In |
Log In |
| Other Growth | 2.84% |
Log In |
Log In |
Log In |
Log In |
| Intersegments | - |
Log In |
Log In |
Log In |
Log In |
| Intersegments Growth | - |
Log In |
Log In |
Log In |
Log In |
| Hospital | - |
Log In |
Log In |
Log In |
Log In |
| Hospital Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| United States and Canada | 4.09B |
Log In |
Log In |
Log In |
Log In |
| United States and Canada Growth | 4.82% |
Log In |
Log In |
Log In |
Log In |
| Rest of World | 1.58B |
Log In |
Log In |
Log In |
Log In |
| Rest of World Growth | 10.22% |
Log In |
Log In |
Log In |
Log In |
| Rest of European Union | 1.12B |
Log In |
Log In |
Log In |
Log In |
| Rest of European Union Growth | 25.22% |
Log In |
Log In |
Log In |
Log In |
| Spain | 423.08M |
Log In |
Log In |
Log In |
Log In |
| Spain Growth | 16.59% |
Log In |
Log In |
Log In |
Log In |